M3315

MJ33 lithium salt

powder, ≥90% (NMR)

• Sinonimo/i: 1-Hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol lithium
• Formula empirica (notazione di Hill): C₂₂H₄₃F₃O₆PLi
• Numero CAS: 199106-13-3
• Peso molecolare: 498.48
• Numero MDL: MFCD03787978
• Codice UNSPSC: 41106300
• ID PubChem: 24278549
• NACRES: NA.77

Proprietà

• Livello qualitativo: 100
• Saggio: ≥90% (NMR)
• Stato: powder
• Colore: white to beige
• Solubilità: H₂O: ≥5 mg/mL (warmed at 60 °C)
• Temperatura di conservazione: 2-8°C
• Stringa SMILE: CCCCCCCCCCCCCCCCOCC(COCC(F)(F)F)OP(OC)([O-])=O.[Li+]
• InChI: 1S/C22H44F3O6P.Li/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-29-18-21(31-32(26,27)28-2)19-30-20-22(23,24)25;/h21H,3-20H2,1-2H3,(H,26,27);/q;+1/p-1; GDLMLQJISATCEL-UHFFFAOYSA-M

Descrizione

Applicazioni

MJ33 lithium salt has been used as a peroxiredoxin VI (Prdx6) inhibitor:

• to study its specific Prdx6 peroxidase activity in vitro and in breast cancer cell line (MCF-7) cell lysates[1]
• to study its effects on a mouse model of acute lung injury associated with exposure to hyperoxia[2]
• to study its potential use as a therapeutic agent[3]

Azioni biochim/fisiol

MJ33 acts as a non-toxic and potent inhibitor of agonist-induced activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase type 2 (NOX2). It also prevents lung injuries associated with lung inflammation in mice. MJ33 is a fluorinated lipid analog, which blocks the enzyme by mimicking the transition state of the substrate.[2]

Novel, active site directed, specific, competitive and reversible inhibitor of phospholipase A₂ (PLA₂).

Informazioni sulla sicurezza

• Codice della classe di stoccaggio: 11 - Combustible Solids
• Classe di pericolosità dell'acqua (WGK): WGK 3
• Punto d’infiammabilità (°F): Not applicable
• Punto d’infiammabilità (°C): Not applicable
• Dispositivi di protezione individuale: Eyeshields, Gloves, type N95 (US)